Herein, we wish to describe the efficient three-step synthesis of a novel highly hindered, but flexible, N-heterocyclic carbene and its coordination chemistry to Ag(i) and Rh(i).
New C2-symmetric bicyclo[2.2.1]hepta-2,5-dienes bearing methyl and phenyl substituents at the 2 and 5 positions were prepared enantiomerically pure through a two-step sequence starting from the readily available bicyclo[2.2.1]hepta-2,5-dione. Due to the instability or volatility of these dienes, their isolation was achieved through the formation of the corresponding stable [RhCl(diene)]2 complexes. These chiral rhodium complexes displayed high activity and enantioselectivity (up to 99% ee) in the rhodium-catalyzed 1,4-addition and 1,2-addition of phenylboronic acid to cyclic enones and N-sulfonylimines, respectively.
The hydrosilylation of terminal alkynes by silanes catalyzed by N-heterocyclic carbene platinum(0)
complexes has been investigated. The alkynes included 1-octyne and phenylacetylene. The silanes
investigated were bis(trimethylsilyloxy)methylsilane, (trimethylsilyloxy)dimethylsilane, tert-butyldimethylsilane, triphenylsilane, phenyldimethylsilane, triethylsilane, and triethoxysilane. X-ray crystal
structures for [Pt(N,N‘-dicyclohexylimidazol-2-ylidene)(η2-dimethylacetylenedicarboxylate)2] (8) and
[Pt{C(E)C(E)−C(E)C(E)}(N,N‘-dimethylbenzimidazol-2-ylidene)(σ-NCCH3)] (10) (E = CO2Me) have
been obtained. A selectivity model, based on structural parameters of the N-heterocyclic carbene, has
been devised in order to rationalize the observed regioselectivity obtained. By a judicious choice of
catalyst, alkyne, and silane, the regioselectivity of the addition can be controlled.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.